WuXi AppTec left BIO amid alleged biosecurity concerns. ... Fierce Pharma Asia—BIO-WuXi break-off; ... The divested franchise accounted for 3.7% of Biocon’s revenue in its fiscal year 2023. 7.

Astellas Pharma Inc. announced it plans to acquire Iveric Bio Inc. in an all-cash deal in which it will pay $40 per Iveric share for a total equity value of roughly $5.9 billion. “Iveric Bio has ...

Ajinomoto Bio-Pharma Services recognized in "Global Biologics" categoryForge Biologics, a member of Ajinomoto-Bio-Pharma Services, recognized in "Global Cell & Gene Therapy" category ...

BIO 2025 brings pharma, biotech, and policy leaders together to tackle industry challenges. Follow our coverage on AI, vaccines, cell & gene therapy, and key discussions from health officials.

DORADO, PUERTO RICO/ ACCESS Newswire/ January 29, 2025/ Pharma-Bio Serv, Inc., a regulatory affairs, quality, compliance, project management and technology transfer support consulting firm that ...

At BIO 2025 in Boston today, pharma and biotech leaders discussed the current state of AI in the drug development life cycle. Skip to main content Monday 21 July 2025 . BlueSky ...

Palisade Bio Inc.’s stock PALI more than doubled in price on Wednesday, after the company announced a licensing agreement with privately held Giiant Pharma Inc. Carlsbad, Calif.-based Palisade ...